argenx to Present at Wells Fargo Healthcare Conference
31 August 2022 - 07:00AM
August 31,
2022Amsterdam, the
Netherlands – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases, today announced
that members of management will participate in a fireside chat at
the Wells Fargo Healthcare Conference on Wednesday, September 7,
2022, at 8:00 a.m. E.T. in Boston, MA.
A live webcast of the presentation may be accessed on the
Investors section of the argenx website at argenx.com/investors. A
replay of the webcast will be available on the argenx website for
approximately 90 days following the presentation.
About argenx
argenx is a global immunology company committed to improving the
lives of people suffering from severe autoimmune diseases.
Partnering with leading academic researchers through its Immunology
Innovation Program (IIP), argenx aims to translate immunology
breakthroughs into a world-class portfolio of novel antibody-based
medicines. argenx developed and is commercializing the
first-and-only approved neonatal Fc receptor (FcRn) blocker in the
U.S., the EU and Japan. The Company is evaluating efgartigimod in
multiple serious autoimmune diseases and advancing several earlier
stage experimental medicines within its therapeutic franchises. For
more information, visit www.argenx.com and follow us on LinkedIn,
Twitter, and Instagram.
For further information, please contact:
Media:
Kelsey Kirkkkirk@argenx.com
Investors:
Beth DelGiaccobdelgiacco@argenx.com
Argen X (EU:ARGX)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Argen X (EU:ARGX)
Historical Stock Chart
Von Mär 2023 bis Mär 2024